Deyuan pharmaceutical: it is proposed to raise no more than 160 million yuan for capital increase to hold no less than 55% equity of Tongli Haiyuan

Deyuan pharmaceutical announced that it plans to raise no more than 160 million yuan (including this amount). After deducting the issuance expenses, it is proposed to increase the capital to hold no less than 55% equity of Tongli Haiyuan, and the capital increase is used for the construction of Tongli Haiyuan Jiangsu Lianyungang Port Co.Ltd(601008) production base, the upgrading of Beijing Daxing R & D center, the upgrading of marketing center and supplementary working capital projects.

(source: financial Associated Press)